TSHR and geroderma osteodysplastica: It is conceivable that in the near future other biologicals or agents (e.g. small molecules targeting the TSHR), currently under active investigation, may be proven to have a relevant role in the management of GO, but, for the time being, solid evidence in this regard is still missing.